Search Results Search Sort by RelevanceMost Recent Policy Forum May 2003 The Virtue of Drawing Lines in Genetic Testing Rosemarie Tong, PhD Virtual Mentor. 2003;5(5):143-145. doi: 10.1001/virtualmentor.2003.5.5.pfor1-0305. State of the Art and Science Nov 2002 Adopting the Unborn Swathi Arekapudi Virtual Mentor. 2002;4(11):331-333. doi: 10.1001/virtualmentor.2002.4.11.gnth1-0211. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. History of Medicine Apr 2022 Why Restoring Birth as Ceremony Can Promote Health Equity Marinah V. Farrell Until the mid-20th century, birth in the United States for Latinx Indigenous peoples was an ancestral ceremony guided by midwives and traditional healers. AMA J Ethics. 2022;24(4):E326-332. doi: 10.1001/amajethics.2022.326. History of Medicine Dec 2021 Living Histories of Structural Racism and Organized Medicine Robert Baker, PhD and Matthew K. Wynia, MD, MPH Mistakes and lessons from AMA history situate the AMA now for antiracist leadership in the health care sector. AMA J Ethics. 2021;23(12):E995-1003. doi: 10.1001/amajethics.2021.995. History of Medicine Apr 2017 How Navigating Uncertainty Motivates Trust in Medicine Jonathan B. Imber, PhD AMA J Ethics. 2017;19(4):391-398. doi: 10.1001/journalofethics.2017.19.4.mhst1-1704. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858.